Rescue Thrombolysis for Medium Vessel Occlusion (RESCUE-TNK)
Status:
Not yet recruiting
Trial end date:
2025-02-15
Target enrollment:
Participant gender:
Summary
The best reperfusion strategy for medium-sized vessel occlusion (MeVO) is not well
established. Given the proven treatment effect of intra-arterial thrombolysis in patients
with large vessel occlusion (LVO), the investigators hypothesized that intra-arterial
tenecteplase (TNK) could increase the recanalization rate of MeVO and thus improve clinical
outcome. The current study aimed to explore the safety and efficacy of intra-arterial TNK in
patients with MeVO.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
General Hospital of Shenyang Military Region
Collaborator:
Cerebrovascular Disease Collaboration & Innovation Alliance of Liaoning